Clinical Trial Update: Study Of Perennial Allergic Rhinitis In Pediatrics [Phase 3]

View source ↗

Summary

GlaxoSmithKline's Phase 3 pediatric trial evaluating perennial allergic rhinitis has completed. The snippet does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Perennial

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED